Bristol-Myers Squibb (BMY) Profit Margin (2008 - 2026)
Bristol-Myers Squibb (BMY) profit margin from Jun 30, 2008 to Mar 31, 2026. The current Bristol-Myers Squibb (BMY) profit margin is 23.30%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Bristol-Myers Squibb (BMY)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 14.64% | -179.01% |
| 2024 | -18.53% | -203.90% |
| 2023 | 17.83% | +30.09% |
| 2022 | 13.71% | -9.09% |
| 2021 | 15.08% | -171.11% |
| 2020 | -21.20% | -261.19% |
| 2019 | 13.15% | -41.60% |
| 2019 | 22.52% | -1.33% |
| 2019 | 22.83% | -20.97% |
| 2019 | 28.89% | +32.45% |
| 2018 | 21.81% | -34.72% |
| 2018 | 33.40% | +410.82% |
| 2018 | 6.54% | -77.15% |
| 2018 | 28.62% | +490.38% |
| 2017 | 4.85% | -69.86% |
| 2017 | 16.08% | -9.68% |
| 2017 | 17.81% | -44.24% |
| 2017 | 31.93% | +39.19% |
| 2016 | 22.94% | -6.05% |
| 2016 | 24.42% | +2.02% |
| 2016 | 23.94% | -12.04% |
| 2016 | 27.21% | +187.97% |
| 2015 | 9.45% | -45.53% |
| 2015 | 17.35% | -655.62% |
| 2015 | -3.12% | -110.64% |
| 2015 | 29.35% | +132.55% |
| 2014 | 12.62% | -31.37% |
| 2014 | 18.39% | +114.75% |
| 2014 | 8.56% | -65.17% |
| 2014 | 24.59% | +57.18% |
| 2013 | 15.64% | -8.11% |
| 2013 | 17.02% | +28.56% |
| 2013 | 13.24% | -16.70% |
| 2013 | 15.90% | +42.92% |
| 2012 | 11.12% | -158.45% |
| 2012 | -19.03% | -231.09% |
| 2012 | 14.52% | -30.76% |
| 2012 | 20.97% | +20.09% |
| 2011 | 17.46% | -3.70% |
| 2011 | 18.13% | +9.22% |
| 2011 | 16.60% | -15.64% |
| 2011 | 19.68% | +23.59% |
| 2010 | 15.92% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | -100.00% |
| 2009 | 56.42% | +179.66% |
| 2009 | 20.18% | -4.25% |
| 2009 | 21.07% | +42.75% |
| 2009 | 14.76% | -50.16% |
| 2008 | 29.62% | +113.65% |
| 2007 | 13.86% | N/A |
Comparison Bristol-Myers Squibb (BMY) profit margin with competitors
Bristol-Myers Squibb (BMY) profit margin is 23.30%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +115.23% |
| LLY | Lilly(Eli) & Company | 37.36% | +60.34% |
| GILD | Gilead Sciences Inc | 29.04% | +24.63% |
| NVS | Novartis AG | 23.34% | +0.17% |
| GSK | GSK Plc | 22.77% | -2.28% |
| JNJ | Johnson & Johnson | 21.76% | -6.61% |
| AMGN | AMGEN Inc | 21.11% | -9.40% |
| AZN | Astrazeneca plc | 20.15% | -13.52% |
| PFE | Pfizer Inc | 18.59% | -20.22% |
| SNY | Sanofi | 14.35% | -38.41% |
| BIIB | Biogen Inc | 12.89% | -44.68% |
| OGN | Organon & Company | 10.00% | -57.08% |
| ABBV | Abbvie Inc | 4.63% | -80.13% |
| GRFS | Grifols SA | 4.29% | -81.59% |